Google News Alert for: cancer
| Vandetanib Shows Clinical Benefit When Combined With Docetaxel For ... Science Daily (press release) - USA It is the first single agent in lung cancer to target both receptors, said Herbst, the study's international principal investigator. ... See all stories on this topic |
This as-it-happens Google Alert is brought to you by Google.
Create another alert.
Manage your alerts.
No comments:
Post a Comment